Generic name |
dupilumab |
---|---|
Strength |
200 mg/1.14 mL prefilled syringe or prefilled pen 300 mg/2 mL prefilled syringe or prefilled pen |
Form |
solution for subcutaneous injection |
Special Authority criteria |
Approval period |
---|---|
INITIAL For the add-on maintenance treatment of patients aged 12 years and up with severe eosinophilic asthma meeting ALL the following criteria:
|
1 year |
FIRST RENEWAL Renewal of coverage requested by a respirologist or allergist with expertise in treating asthma1 will be considered for patients aged 12 years and up whose:
|
1 year |
SECOND AND SUBSEQUENT RENEWAL Renewal of coverage requested by a respirologist or allergist with expertise in treating asthma1 will be considered for patients aged 12 years and up whose:
|
1 year |